XNYS 12 Dec, 2025 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| R. Sharon Smith | Exec VP & Group COO | Purchase of securities on an exchange or from another person at price $ 10.25 per share. | 12 Nov 2025 | 20 | 170,952 (0%) | 0% | 10.3 | 205 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 232,816 | 513,617 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 45,650 | 280,801 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 500,000 | 500,000 | - | - | Performance Stock Option | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 350,375 | 350,375 | - | - | Performance Stock Option | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 66,519 | 123,439 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Group COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 55,433 | 106,200 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Group COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 284,125 | 284,125 | - | - | Performance Stock Option | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 4,126 | 4,126 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | 29 Sep 2025 | 39,179 | 0 | - | - | Restricted Stock Units | ||
| Michael D. Price | Director | 29 Sep 2025 | 39,179 | 205,477 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| Lisa G. Iglesias | Director | 29 Sep 2025 | 67,777 | 82,327 (0%) | 0% | 0 | Common Stock | ||
| Lisa G. Iglesias | Director | 29 Sep 2025 | 67,777 | 0 | - | - | Restricted Stock Units | ||
| Kristi Ann Matus | Director | 29 Sep 2025 | 39,179 | 0 | - | - | Restricted Stock Units | ||
| Kristi Ann Matus | Director | 29 Sep 2025 | 39,179 | 48,179 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| Jeffrey Scott Stein | Director | 29 Sep 2025 | 167,807 | 0 | - | - | Restricted Stock Units | ||
| Jeffrey Scott Stein | Director | 29 Sep 2025 | 167,807 | 217,807 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| Ian D. Haft | Director | 29 Sep 2025 | 131,921 | 0 | - | - | Restricted Stock Units | ||
| Ian D. Haft | Director | 29 Sep 2025 | 131,921 | 131,921 (0%) | 0% | - | Common Stock, par value $0.01 per share | ||
| Joan M. Lamm-Tennant | Director | 29 Sep 2025 | 106,990 | 106,990 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | ||
| Joan M. Lamm-Tennant | Director | 29 Sep 2025 | 106,990 | 0 | - | - | Restricted Stock Units | ||
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 193,353 | 1,107,811 (2%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.72 per share. | 29 Sep 2025 | 350,188 | 914,458 (2%) | 0% | 9.7 | 3,403,827 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | 29 Sep 2025 | 661,355 | 1,264,646 (2%) | 1% | 0 | Common Stock | ||
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 174,961 | 174,961 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | 29 Sep 2025 | 661,355 | 0 | - | - | Deferred Share Units | ||
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.54 per share. | 29 Sep 2025 | 25,000 | 1,021,777 (2%) | 0% | 8.5 | 213,500 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.34 per share. | 29 Sep 2025 | 111,034 | 996,777 (2%) | 0% | 8.3 | 926,024 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | 29 Sep 2025 | 165,361 | 321,443 (0%) | 0% | 0 | Common Stock | ||
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 46,556 | 46,556 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | 29 Sep 2025 | 165,361 | 0 | - | - | Deferred Share Units | ||
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.34 per share. | 29 Sep 2025 | 16,420 | 291,811 (0%) | 0% | 8.3 | 136,943 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 42,515 | 308,231 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.72 per share. | 29 Sep 2025 | 55,727 | 265,716 (0%) | 0% | 9.7 | 541,666 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | 29 Sep 2025 | 129,146 | 248,778 (0%) | 0% | 0 | Common Stock | ||
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.72 per share. | 29 Sep 2025 | 43,522 | 205,256 (0%) | 0% | 9.7 | 423,034 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | 29 Sep 2025 | 129,146 | 0 | - | - | Deferred Share Units | ||
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.34 per share. | 29 Sep 2025 | 2,814 | 170,932 (0%) | 0% | 8.3 | 23,469 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | 29 Sep 2025 | 145,135 | 219,842 (0%) | 0% | 0 | Common Stock | ||
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 76,627 | 76,627 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | 29 Sep 2025 | 145,135 | 0 | - | - | Deferred Share Units | ||
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.72 per share. | 29 Sep 2025 | 48,910 | 170,932 (0%) | 0% | 9.7 | 475,405 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 2,814 | 173,746 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | 29 Sep 2025 | 29,832 | 48,288 (0%) | 0% | 0 | Common Stock | ||
| Daniel McGinnis | Sr. MD & COO | 29 Sep 2025 | 29,832 | 0 | - | - | Deferred Share Units | ||
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.72 per share. | 29 Sep 2025 | 10,053 | 38,235 (0%) | 0% | 9.7 | 97,715 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.03 per share. | 11 Aug 2025 | 25,000 | 603,291 (1%) | 0% | 7.0 | 175,750 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 163,695 | 235,151 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 39,586 | 56,920 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 35,307 | 50,767 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 18,188 | 26,152 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 32,097 | 46,151 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 118,045 | 189,501 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 39,179 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 67,777 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 106,990 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 39,179 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 167,807 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,053 | 131,921 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 14 May 2025 | 40,000 | 578,291 (1%) | 0% | 6.5 | 260,000 | Common Stock |
| Michael D. Price | Director | Purchase of securities on an exchange or from another person at price $ 6.54 per share. | 14 May 2025 | 63 | 166,298 (0%) | 0% | 6.5 | 412 | Common Stock, par value $0.01 per share |
| Michael D. Price | Director | Purchase of securities on an exchange or from another person at price $ 6.49 per share. | 14 May 2025 | 76,923 | 166,235 (0%) | 0% | 6.5 | 499,230 | Common Stock, par value $0.01 per share |
| Jeffrey Scott Stein | Director | Purchase of securities on an exchange or from another person at price $ 6.48 per share. | 14 May 2025 | 5,000 | 50,000 (0%) | 0% | 6.5 | 32,400 | Common Stock, par value $0.01 per share |
| Jeffrey Scott Stein | Director | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 14 May 2025 | 10,000 | 45,000 (0%) | 0% | 6.5 | 64,500 | Common Stock, par value $0.01 per share |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 32,126 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 60,724 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 99,937 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 32,126 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 160,754 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 5,728 | 124,868 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 24,327 | 71,456 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 24,327 | 551,743 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 13,452 | 538,291 (1%) | 0% | 8.4 | 112,862 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 1,908 | 5,604 | - | - | Restricted Stock Units | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 1,908 | 70,795 (0%) | 0% | 0 | Common Stock | |
| Robert B. Eisman | Sr. MD & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 687 | 70,108 (0%) | 0% | 8.4 | 5,764 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 1,703 | 121,599 (0%) | 0% | 8.4 | 14,288 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,726 | 14,054 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,726 | 123,302 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,167 | 16,117 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 189 | 128,604 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 189 | 128,415 (0%) | 0% | 8.4 | 1,586 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 189 | 15,928 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,167 | 96,877 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,961 | 145,135 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 238 | 15,460 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 4,961 | 15,698 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 238 | 74,707 (0%) | 0% | 8.4 | 1,997 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 238 | 74,945 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 2,584 | 8,058 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 2,584 | 29,832 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 94 | 7,964 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 94 | 18,550 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 13 Mar 2025 | 94 | 18,456 (0%) | 0% | 8.4 | 789 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 267 | 156,349 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 5,562 | 165,361 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 267 | 17,334 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 5,562 | 17,601 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.39 per share. | 11 Mar 2025 | 267 | 156,349 (0%) | 0% | 8.4 | 2,240 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 274,612 | 661,355 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 10,809 | 538,225 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 10,809 | 527,416 (1%) | 0% | 9.2 | 99,010 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 21,117 | 50,852 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,271 | 68,887 (0%) | 0% | 0 | Common Stock | |
| Robert B. Eisman | Sr. MD & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 1,271 | 68,887 (0%) | 0% | 9.2 | 11,642 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 2,446 | 156,082 (0%) | 0% | 9.2 | 22,405 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,446 | 158,528 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 66,577 | 159,799 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 1,967 | 118,576 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 1,967 | 118,576 (0%) | 0% | 9.2 | 18,018 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 53,999 | 129,146 | - | - | Deferred Share Units | |
| David Barranco | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 45,907 | 91,710 | - | - | Deferred Share Units | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 7,379 | 128,415 (0%) | 0% | 9.2 | 67,592 | Common Stock |
| David Barranco | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 17,519 | 135,794 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,154 | 76,861 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 59,408 | 140,174 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 2,154 | 74,707 (0%) | 0% | 9.2 | 19,731 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 14,838 | 27,248 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.16 per share. | 06 Mar 2025 | 6,736 | 18,456 (0%) | 0% | 9.2 | 61,702 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 16,874 | 25,192 (0%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 888 | 528,304 (1%) | 0% | - | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 22,576 | 386,743 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 23,464 | 95,783 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 24,610 | 364,167 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 25,762 | 119,247 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 888 | 527,416 (1%) | 0% | 9.3 | 8,258 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,152 | 528,568 (1%) | 0% | - | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 1,152 | 527,416 (1%) | 0% | 9.7 | 11,186 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 212 | 67,616 (0%) | 0% | 9.3 | 1,972 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,628 | 29,735 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,840 | 7,512 | - | - | Restricted Stock Units | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,787 | 28,107 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 233 | 67,849 (0%) | 0% | - | Common Stock | |
| Robert B. Eisman | Sr. MD & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 233 | 67,616 (0%) | 0% | 9.7 | 2,262 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 212 | 67,828 (0%) | 0% | - | Common Stock | |
| Robert B. Eisman | Sr. MD & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,020 | 9,352 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 663 | 156,745 (0%) | 0% | - | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 201 | 156,082 (0%) | 0% | 9.3 | 1,869 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 6,230 | 28,837 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,567 | 87,749 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,674 | 23,163 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,473 | 93,222 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 201 | 156,283 (0%) | 0% | - | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 663 | 156,082 (0%) | 0% | 9.7 | 6,438 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 400 | 117,009 (0%) | 0% | - | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 582 | 117,191 (0%) | 0% | - | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 582 | 116,609 (0%) | 0% | 9.7 | 5,651 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 400 | 116,609 (0%) | 0% | 9.3 | 3,720 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,051 | 23,381 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,469 | 70,946 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,601 | 18,780 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,201 | 75,147 | - | - | Deferred Share Units | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 2,099 | 118,275 (0%) | 0% | 9.3 | 19,521 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,725 | 117,530 (0%) | 0% | - | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 2,370 | 115,160 (0%) | 0% | 9.7 | 23,013 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,214 | 120,374 (0%) | 0% | - | Common Stock | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,214 | 21,284 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,725 | 26,498 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 532 | 75,239 (0%) | 0% | - | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 532 | 74,707 (0%) | 0% | 9.3 | 4,948 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,556 | 25,720 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,915 | 76,237 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 4,529 | 80,766 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5,061 | 20,659 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 641 | 75,348 (0%) | 0% | - | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 641 | 74,707 (0%) | 0% | 9.7 | 6,224 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 28 Feb 2025 | 330 | 8,318 (0%) | 0% | 9.7 | 3,204 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 28 Feb 2025 | 300 | 8,318 (0%) | 0% | 9.3 | 2,790 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,862 | 13,249 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,532 | 10,103 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,607 | 10,642 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,307 | 12,410 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 300 | 8,618 (0%) | 0% | - | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 330 | 8,648 (0%) | 0% | - | Common Stock | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 26,398 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 54,996 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 94,209 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 26,398 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 155,026 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 119,140 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 22,460 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 51,058 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 90,271 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 22,460 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 151,088 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 115,202 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Purchase of securities on an exchange or from another person at price $ 11.27 per share. | 26 Sep 2024 | 2,700 | 2,700 (0%) | 0% | 11.3 | 30,429 | Common Stock, par value $0.01 per share |
| Kristi Ann Matus | Director | Purchase of securities on an exchange or from another person at price $ 11.16 per share. | 26 Sep 2024 | 6,300 | 9,000 (0%) | 0% | 11.2 | 70,308 | Common Stock, par value $0.01 per share |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Purchase of securities on an exchange or from another person at price $ 10.64 per share. | 08 Aug 2024 | 1,100 | 74,707 (0%) | 0% | 10.6 | 11,704 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.70 per share. | 07 Aug 2024 | 12,273 | 514,689 (1%) | 0% | 10.7 | 131,321 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.64 per share. | 07 Aug 2024 | 47 | 526,716 (1%) | 0% | 10.6 | 500 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.60 per share. | 07 Aug 2024 | 700 | 527,416 (1%) | 0% | 10.6 | 7,420 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 07 Aug 2024 | 10,953 | 526,669 (1%) | 0% | 11 | 120,483 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.85 per share. | 07 Aug 2024 | 1,027 | 515,716 (1%) | 0% | 10.9 | 11,143 | Common Stock |
| Michael D. Price | Director | Purchase of securities on an exchange or from another person at price $ 11.21 per share. | 07 Aug 2024 | 84,577 | 89,312 (0%) | 0% | 11.2 | 948,108 | Common Stock, par value $0.01 per share |
| Michael D. Price | Director | Purchase of securities on an exchange or from another person at price $ 10.85 per share. | 07 Aug 2024 | 4,471 | 4,471 (0%) | 0% | 10.8 | 48,510 | Common Stock, par value $0.01 per share |
| Michael D. Price | Director | Purchase of securities on an exchange or from another person at price $ 10.97 per share. | 07 Aug 2024 | 264 | 4,735 (0%) | 0% | 11.0 | 2,896 | Common Stock, par value $0.01 per share |
| David Trick | Exec VP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 10.83 per share. | 07 Aug 2024 | 1,800 | 154,182 (0%) | 0% | 10.8 | 19,494 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 10.69 per share. | 07 Aug 2024 | 1,500 | 155,882 (0%) | 0% | 10.7 | 16,035 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 10.86 per share. | 07 Aug 2024 | 200 | 154,382 (0%) | 0% | 10.9 | 2,172 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 10.63 per share. | 07 Aug 2024 | 200 | 156,082 (0%) | 0% | 10.6 | 2,126 | Common Stock |
| Jeffrey Scott Stein | Director | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 07 Aug 2024 | 25,000 | 35,000 (0%) | 0% | 10.8 | 270,500 | Common Stock, par value $0.01 per share |
| Stephen M. Ksenak | Sr. MD & General Counsel | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 07 Aug 2024 | 5,000 | 116,609 (0%) | 0% | 11 | 55,000 | Common Stock |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 17,963 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 46,561 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 85,774 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 17,963 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 146,591 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 110,705 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 14,264 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 42,862 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 82,075 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 14,264 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 142,892 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 107,006 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 72,313 | 145,009 | - | - | Restricted Stock Units | |
| Robert B. Eisman | Sr. MD & CAO | 13 Mar 2024 | 5,671 | 11,372 | - | - | Restricted Stock Units | ||
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 17,487 | 35,067 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 14,179 | 28,432 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 16,069 | 32,223 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 15,597 | 31,276 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 8,034 | 16,111 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,193 | 503,609 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 1,193 | 502,416 (1%) | 0% | 15.4 | 18,348 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 1,193 | 103,009 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 30,313 | 72,696 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 30,313 | 339,557 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2024 | 87 | 67,703 (0%) | 0% | 0 | Common Stock | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2024 | 2,384 | 26,320 | - | - | Deferred Share Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2024 | 2,384 | 5,701 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2024 | 87 | 8,085 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2024 | 87 | 67,616 (0%) | 0% | 15.4 | 1,338 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 270 | 152,652 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 7,349 | 82,182 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 7,349 | 17,580 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 270 | 24,929 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 270 | 152,382 (0%) | 0% | 15.4 | 4,153 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 218 | 111,609 (0%) | 0% | 15.4 | 3,353 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 5,959 | 66,477 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 5,959 | 14,253 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 218 | 20,212 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 218 | 111,827 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 7,001 | 16,154 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 7,001 | 114,328 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 2,523 | 111,805 (0%) | 0% | 15.4 | 38,804 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 6,356 | 15,679 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 6,356 | 71,322 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.38 per share. | 08 Mar 2024 | 233 | 73,607 (0%) | 0% | 15.4 | 3,584 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 233 | 73,840 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 233 | 22,035 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 888 | 503,304 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 22,576 | 309,244 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 22,576 | 104,202 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 888 | 126,778 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 888 | 502,416 (1%) | 0% | 16.2 | 14,377 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2024 | 65 | 67,681 (0%) | 0% | 0 | Common Stock | ||
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2024 | 1,775 | 23,936 | - | - | Deferred Share Units | ||
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2024 | 1,775 | 8,172 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2024 | 65 | 9,947 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2024 | 65 | 67,616 (0%) | 0% | 16.2 | 1,052 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 201 | 152,583 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 5,473 | 74,833 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 5,473 | 25,199 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 201 | 30,672 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 201 | 152,382 (0%) | 0% | 16.2 | 3,254 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 163 | 111,609 (0%) | 0% | 16.2 | 2,639 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 4,438 | 60,518 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,438 | 20,430 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 163 | 24,868 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 163 | 111,772 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 1,880 | 107,327 (0%) | 0% | 16.2 | 30,437 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 5,215 | 23,155 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 5,215 | 109,207 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 179 | 73,786 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 4,882 | 64,966 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,882 | 22,268 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 179 | 27,150 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.19 per share. | 03 Mar 2024 | 179 | 73,607 (0%) | 0% | 16.2 | 2,898 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 92 | 8,410 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 2,515 | 7,571 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 2,515 | 8,077 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 92 | 10,592 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.18 per share. | 03 Mar 2024 | 92 | 8,318 (0%) | 0% | 16.2 | 1,489 | Common Stock |
| Sharon R. Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 196 | 32,688 | - | - | Restricted Stock Units | |
| Sharon Smith R. | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 5,359 | 27,329 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 5,723 | 28,370 | - | - | Restricted Stock Units | |
| Sharon Smith R. | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 196 | 73,607 (0%) | 0% | 16.9 | 3,320 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2024 | 71 | 67,616 (0%) | 0% | 16.9 | 1,203 | Common Stock | |
| Barranco David | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 5,723 | 106,055 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 178 | 29,903 | - | - | Restricted Stock Units | |
| Ksenak Stephen M. | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 4,872 | 56,080 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2024 | 71 | 67,687 (0%) | 0% | 0 | Common Stock | ||
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 2,590 | 8,318 (0%) | 0% | 16.9 | 43,875 | Common Stock |
| Trick David | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 6,008 | 69,360 | - | - | Deferred Share Units | |
| Barranco David | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 2,063 | 103,992 (0%) | 0% | 16.9 | 34,947 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 338 | 19,942 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 196 | 73,803 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,524 | 17,418 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 6,734 | 10,908 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 220 | 152,602 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 338 | 4,512 (0%) | 0% | 0 | Common Stock | |
| B. Eisman Robert | Sr. MD & CAO | 28 Feb 2024 | 1,949 | 10,012 | - | - | Restricted Stock Units | ||
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 220 | 152,382 (0%) | 0% | 16.9 | 3,727 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,524 | 5,056 | - | - | Deferred Share Units | |
| M. Ksenak Stephen | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 178 | 111,609 (0%) | 0% | 16.9 | 3,015 | Common Stock |
| Trick David | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 220 | 30,873 | - | - | Restricted Stock Units | |
| B. Robert Eisman | Sr. MD & CAO | 28 Feb 2024 | 1,949 | 22,161 | - | - | Deferred Share Units | ||
| Eisman B. Robert | Sr. MD & CAO | 28 Feb 2024 | 71 | 11,961 | - | - | Restricted Stock Units | ||
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,359 | 60,084 | - | - | Deferred Share Units | |
| Stephen Ksenak M. | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 178 | 111,787 (0%) | 0% | 0 | Common Stock | |
| McGinnis Daniel | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 338 | 4,174 (0%) | 0% | 16.9 | 5,726 | Common Stock |
| M. Ksenak Stephen | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 4,872 | 25,031 | - | - | Restricted Stock Units | |
| McGinnis Daniel | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 6,734 | 10,684 | - | - | Restricted Stock Units | |
| Trick David | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 6,008 | 31,093 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 24,780 | 286,668 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 975 | 503,391 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.94 per share. | 28 Feb 2024 | 975 | 502,416 (1%) | 0% | 16.9 | 16,517 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 975 | 152,446 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 24,780 | 127,666 | - | - | Restricted Stock Units | |
| Robert Eisman B. | Sr. MD & CAO | 21 Feb 2024 | 1,041 | 68,657 (0%) | 0% | 0 | Common Stock | ||
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 8,257 | 502,416 (1%) | 0% | 16.2 | 134,176 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 50,074 | 63,352 | - | - | Deferred Share Units | |
| Ksenak Stephen M. | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 1,861 | 113,470 (0%) | 0% | 0 | Common Stock | |
| B. Robert Eisman | Sr. MD & CAO | 21 Feb 2024 | 15,880 | 20,212 | - | - | Deferred Share Units | ||
| Smith R. Sharon | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 2,046 | 75,653 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 43,079 | 54,725 | - | - | Deferred Share Units | |
| David Barranco | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 45,803 | 45,803 | - | - | Deferred Share Units | |
| M. Stephen Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 1,861 | 111,609 (0%) | 0% | 16.2 | 30,241 | Common Stock |
| Sharon R. Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 2,046 | 73,607 (0%) | 0% | 16.3 | 33,248 | Common Stock |
| LeBlanc Claude L. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 207,494 | 261,888 | - | - | Deferred Share Units | |
| Barranco David | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,143 | 102,475 (0%) | 0% | 0 | Common Stock | |
| Barranco David | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 2,143 | 100,332 (0%) | 0% | 16.3 | 34,824 | Common Stock |
| Trick David | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 2,101 | 154,483 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.25 per share. | 21 Feb 2024 | 2,101 | 152,382 (0%) | 0% | 16.2 | 34,141 | Common Stock |
| M. Stephen Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 40,442 | 51,208 | - | - | Deferred Share Units | |
| L. LeBlanc Claude | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 8,257 | 510,673 (1%) | 0% | 0 | Common Stock | |
| B. Eisman Robert | Sr. MD & CAO | 21 Feb 2024 | 1,041 | 67,616 (0%) | 0% | 16.2 | 16,916 | Common Stock | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 39,563 | - | - | Restricted Stock Units | |
| Matus Kristi Ann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 10,965 | - | - | Restricted Stock Units | |
| Scott Stein Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 139,593 | - | - | Restricted Stock Units | |
| D. Haft Ian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 103,707 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 10,965 | - | - | Restricted Stock Units | |
| M. Lamm-Tennant Joan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 78,776 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 7,818 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 36,416 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 75,629 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 7,818 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 136,446 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 100,560 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.29 per share. | 01 Sep 2023 | 2,500 | 502,416 (1%) | 0% | 13.3 | 33,225 | Common Stock |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 3,884 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 32,482 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 71,695 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 3,884 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 132,512 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 96,626 | - | - | Restricted Stock Units | |
| Michael D. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 315 | 315 | - | - | Restricted Stock Units | |
| Kristi Ann Matus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 315 | 315 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 28,913 | - | - | Restricted Stock Units | |
| David Lawrence Herzog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 93,057 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 68,126 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 128,943 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 93,057 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 29,925 | 54,394 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 1,573 | 501,489 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.41 per share. | 08 Mar 2023 | 1,573 | 499,916 (1%) | 0% | 16.4 | 25,813 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 1,573 | 183,346 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 29,925 | 153,421 | - | - | Restricted Stock Units | |
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2023 | 87 | 67,703 (0%) | 0% | 0 | Common Stock | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2023 | 2,383 | 4,332 | - | - | Deferred Share Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2023 | 2,383 | 12,032 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2023 | 87 | 14,415 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 08 Mar 2023 | 87 | 67,616 (0%) | 0% | 16.4 | 1,428 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 348 | 152,730 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 7,269 | 13,278 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 7,269 | 37,101 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 348 | 44,370 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.41 per share. | 08 Mar 2023 | 348 | 152,382 (0%) | 0% | 16.4 | 5,711 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 282 | 111,891 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 5,894 | 10,766 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 5,894 | 30,081 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 282 | 35,975 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.41 per share. | 08 Mar 2023 | 282 | 111,609 (0%) | 0% | 16.4 | 4,628 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 6,999 | 103,904 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.41 per share. | 08 Mar 2023 | 3,572 | 100,332 (0%) | 0% | 16.4 | 58,617 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 6,999 | 34,093 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 301 | 73,908 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.41 per share. | 08 Mar 2023 | 301 | 73,607 (0%) | 0% | 16.4 | 4,939 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 301 | 39,171 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 6,287 | 32,884 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 6,287 | 11,646 | - | - | Deferred Share Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 70,398 | 184,919 | - | - | Restricted Stock Units | |
| Robert B. Eisman | Sr. MD & CAO | 03 Mar 2023 | 5,521 | 14,502 | - | - | Restricted Stock Units | ||
| David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 17,024 | 44,718 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 13,803 | 36,257 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 15,644 | 41,092 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 15,184 | 39,472 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 7,822 | 20,280 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 24,469 | 114,521 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 1,286 | 501,202 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 1,286 | 499,916 (1%) | 0% | 16.5 | 21,283 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 1,286 | 138,990 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 24,469 | 24,469 | - | - | Deferred Share Units | |
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2023 | 1,949 | 1,949 | - | - | Deferred Share Units | ||
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2023 | 1,949 | 8,981 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2023 | 71 | 10,930 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2023 | 71 | 67,687 (0%) | 0% | 0 | Common Stock | ||
| Robert B. Eisman | Sr. MD & CAO | 28 Feb 2023 | 71 | 67,616 (0%) | 0% | 16.5 | 1,175 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 220 | 152,602 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,009 | 6,009 | - | - | Deferred Share Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,009 | 27,694 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 220 | 33,703 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 220 | 152,382 (0%) | 0% | 16.6 | 3,641 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 178 | 111,787 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,872 | 4,872 | - | - | Deferred Share Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,872 | 22,454 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 178 | 27,326 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.55 per share. | 28 Feb 2023 | 178 | 111,609 (0%) | 0% | 16.6 | 2,946 | Common Stock |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 2,063 | 96,905 (0%) | 0% | 16.6 | 34,143 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 5,724 | 25,448 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 5,724 | 98,968 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 5,359 | 5,359 | - | - | Deferred Share Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 196 | 73,607 (0%) | 0% | 16.6 | 3,244 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 196 | 73,803 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 196 | 29,647 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 5,359 | 24,288 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 2,561 | 4,174 (0%) | 0% | 16.6 | 42,385 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 2,532 | 2,532 | - | - | Deferred Share Units | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 2,532 | 12,458 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 330 | 14,990 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,735 | 15,320 | - | - | Restricted Stock Units | |
| Daniel McGinnis | Sr. MD & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 28 Feb 2023 | 330 | 4,174 (0%) | 0% | 16.6 | 5,462 | Common Stock |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 330 | 4,504 (0%) | 0% | 0 | Common Stock | |
| Daniel McGinnis | Sr. MD & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,735 | 6,735 (0%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 180,352 | 592,625 (1%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 92,709 | 499,916 (1%) | 0% | 16.2 | 1,503,740 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | 22 Feb 2023 | 16,777 | 76,366 (0%) | 0% | 0 | Common Stock | ||
| Robert B. Eisman | Sr. MD & CAO | 22 Feb 2023 | 8,750 | 67,616 (0%) | 0% | 16.2 | 141,925 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 47,535 | 176,635 (0%) | 0% | 0 | Common Stock | |
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 24,253 | 152,382 (0%) | 0% | 16.2 | 393,384 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 36,351 | 130,215 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 18,606 | 111,609 (0%) | 0% | 16.2 | 301,789 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 41,493 | 114,733 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 21,489 | 93,244 (0%) | 0% | 16.2 | 348,552 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.22 per share. | 22 Feb 2023 | 17,238 | 73,607 (0%) | 0% | 16.2 | 279,600 | Common Stock |
| R. Sharon Smith | Exec VP & Chief Strategy Offr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 33,555 | 90,845 (0%) | 0% | 0 | Common Stock | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 25,636 | - | - | Restricted Stock Units | |
| C. James Prieur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 94,390 | - | - | Restricted Stock Units | |
| David Lawrence Herzog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 89,780 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 64,849 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 125,666 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 89,780 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 13,784 | 420,384 (0%) | 0% | 0 | Common Stock | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 13,784 | 140,276 | - | - | Restricted Stock Units | |
| Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.44 per share. | 02 Jan 2023 | 8,111 | 412,273 (0%) | 0% | 17.4 | 141,456 | Common Stock |
| Robert B. Eisman | Sr. MD & CAO | 02 Jan 2023 | 1,282 | 11,001 | - | - | Restricted Stock Units | ||
| Robert B. Eisman | Sr. MD & CAO | 02 Jan 2023 | 728 | 59,589 (0%) | 0% | 17.4 | 12,696 | Common Stock | |
| Robert B. Eisman | Sr. MD & CAO | 02 Jan 2023 | 1,282 | 60,317 (0%) | 0% | 0 | Common Stock | ||
| David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.44 per share. | 02 Jan 2023 | 2,065 | 129,100 (0%) | 0% | 17.4 | 36,014 | Common Stock |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 3,633 | 33,923 | - | - | Restricted Stock Units | |
| David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 3,633 | 131,165 (0%) | 0% | 0 | Common Stock | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,778 | 27,504 | - | - | Restricted Stock Units | |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. | 02 Jan 2023 | 1,579 | 93,864 (0%) | 0% | 17.4 | 27,538 | Common Stock |
| Stephen M. Ksenak | Sr. MD & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,778 | 95,443 (0%) | 0% | 0 | Common Stock | |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 3,205 | 31,172 | - | - | Restricted Stock Units | |
| David Barranco | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.44 per share. | 02 Jan 2023 | 1,341 | 73,240 (0%) | 0% | 17.4 | 23,387 | Common Stock |
| David Barranco | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 3,205 | 74,581 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,564 | 29,843 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Senior Managing Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2023 | 2,564 | 58,747 (0%) | 0% | 0 | Common Stock | |
| R. Sharon Smith | Senior Managing Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.44 per share. | 02 Jan 2023 | 1,457 | 57,290 (0%) | 0% | 17.4 | 25,410 | Common Stock |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 22,587 | - | - | Restricted Stock Units | |
| C. James Prieur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 91,341 | - | - | Restricted Stock Units | |
| David Lawrence Herzog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 86,731 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 61,800 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 122,617 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 86,731 | - | - | Restricted Stock Units | |
| Lisa G. Iglesias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 19,020 | - | - | Restricted Stock Units | |
| C. James Prieur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 87,774 | - | - | Restricted Stock Units | |
| David Lawrence Herzog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 83,164 | - | - | Restricted Stock Units | |
| Joan M. Lamm-Tennant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 58,233 | - | - | Restricted Stock Units | |
| Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 119,050 | - | - | Restricted Stock Units | |
| Ian D. Haft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 83,164 | - | - | Restricted Stock Units | |
| R. Sharon Smith | Senior Managing Director | Purchase of securities on an exchange or from another person at price $ 10.05 per share. | 20 May 2022 | 1,000 | 56,183 (0%) | 0% | 10.1 | 10,050 | Common Stock |
| Claude L. LeBlanc | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.72 per share. | 13 May 2022 | 3,000 | 406,600 (0%) | 0% | 8.7 | 26,160 | Common Stock |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.50 per share. | 13 May 2022 | 4 | 65,000 (0%) | 0% | 8.5 | 34 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.45 per share. | 13 May 2022 | 5,000 | 64,996 (0%) | 0% | 8.5 | 42,250 | Common Stock, par value $0.01 per share |
| Lisa G. Iglesias | Director | Purchase of securities on an exchange or from another person at price $ 7.99 per share. | 12 May 2022 | 6,250 | 14,550 (0%) | 0% | 8.0 | 49,938 | Common Stock |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.45 per share. | 12 May 2022 | 300 | 55,000 (0%) | 0% | 8.5 | 2,535 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 12 May 2022 | 136 | 59,996 (0%) | 0% | 8.6 | 1,163 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.54 per share. | 12 May 2022 | 4,860 | 59,860 (0%) | 0% | 8.5 | 41,504 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.44 per share. | 12 May 2022 | 5,000 | 54,700 (0%) | 0% | 8.4 | 42,200 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.42 per share. | 12 May 2022 | 4,420 | 49,700 (0%) | 0% | 8.4 | 37,216 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.41 per share. | 12 May 2022 | 280 | 45,280 (0%) | 0% | 8.4 | 2,355 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.06 per share. | 12 May 2022 | 4,663 | 45,000 (0%) | 0% | 8.1 | 37,584 | Common Stock, par value $0.01 per share |
| C. James Prieur | Director | Purchase of securities on an exchange or from another person at price $ 8.05 per share. | 12 May 2022 | 3,900 | 40,337 (0%) | 0% | 8.1 | 31,395 | Common Stock, par value $0.01 per share |